HCA Healthcare (NYSE:HCA – Get Free Report)‘s stock had its “equal weight” rating reiterated by equities researchers at Barclays in a report released on Wednesday,Benzinga reports. They currently have a $427.00 price target on the stock, down from their prior price target of $496.00. Barclays‘s price target would indicate a potential upside of 0.93% from the stock’s previous close.
A number of other equities research analysts have also issued reports on HCA. Weiss Ratings lowered HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Wells Fargo & Company dropped their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research note on Monday, April 27th. Cantor Fitzgerald lowered their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a report on Tuesday. Argus reduced their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Finally, Jefferies Financial Group restated a “buy” rating and set a $525.00 target price on shares of HCA Healthcare in a research report on Friday, April 24th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $497.14.
View Our Latest Stock Analysis on HCA Healthcare
HCA Healthcare Stock Up 1.4%
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company’s revenue was up 4.3% compared to the same quarter last year. During the same period in the prior year, the company posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts anticipate that HCA Healthcare will post 30.07 EPS for the current year.
Institutional Investors Weigh In On HCA Healthcare
Institutional investors have recently modified their holdings of the stock. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare during the 4th quarter valued at approximately $29,000. Palisade Asset Management LLC bought a new position in HCA Healthcare during the third quarter valued at $26,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $31,000. Cedar Mountain Advisors LLC bought a new position in HCA Healthcare during the 1st quarter valued at about $33,000. Finally, MCF Advisors LLC boosted its position in shares of HCA Healthcare by 213.0% during the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after buying an additional 49 shares during the period. 62.73% of the stock is owned by institutional investors.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- Drone Stocks Are Down, But Defense Backlogs Tell a Different Story
- Industrials Are Leading in 2026, But These ETFs Take Different Routes
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
